Dynasty Market Report — July 16, 2026
The Lede
The dynasty market is in full summer-velocity mode, with multiple role-clarifying camp developments driving a cluster of 70%+ single-week DME surges — the kind of compressed movement that creates instant arbitrage windows before league-mates adjust their boards. The loudest signal today isn't any individual player; it's the pattern: depth-chart vacuums are snapping shut fast, and managers sitting on wait-and-see are already late.
Who's Rising
Jimmy Horn (DME 1,328, +74.97%) is the headliner here — Carolina's receiver room remains a wide-open competition, and Horn's camp buzz has clearly reached the DME's snap-share probability model hard enough to push him into legitimate trade-target territory. Audric Estime (DME 1,286, +77.62%) is the most actionable of the group: with New Orleans continuing to build around a power-run identity, Estime's week-over-week surge looks like role confirmation rather than speculation, and his DME still sits in a range where you can acquire him without overpaying. KeAndre Lambert-Smith (DME 1,233, +71.01%) and Joshua Palmer (DME 1,239, +75.99%) are both riding the LAC/BUF target-share reshuffling — hold both if you own them, but the buying window is tightening by the day.
Who's Falling
Carson Beck's slide to DME 1,855 (-11.71%) is the most structurally concerning drop on the board — a double-digit single-week decline on a young QB in Superflex is a flashing yellow light, not a dip to ignore, and Arizona's depth chart deserves a hard second look before committing. Brandon Aiyuk (DME 1,515, -4.36%) and Chimere Dike (DME 1,496, -5.79%) are softer sells — both carry legitimate role floors — but the Dike number is interesting given Daniel Bellinger's surge in Tennessee (DME 1,139, +72.84%), suggesting a quiet target-share redistribution is already being priced in at Nashville.
The Move
Sell Chimere Dike (DME 1,496) into any remaining perceived value and use the return to buy Audric Estime (DME 1,286) straight up or as the centerpiece of an offer. Estime's role trajectory is hardening, his DME still has a ceiling well above current price, and Dike's number may not hold once Bellinger's volume claim is fully reflected across the market.